Variables | RR-TB N (%) | Not RR-TB N (%) | COR (95% CI) | AOR(95%CI) | P Value |
---|---|---|---|---|---|
Gender | |||||
āMale | 95 (14.6)% | 1012 (85.8) | reference | Ā | Ā |
āFemales | 91 (11.8) | 678 (88.2) | 1.43 (1.06ā1.52) | 1.5 (1.10ā1.99) | 0.02 |
Age-group years | |||||
ā0ā15 | 8 (7.9) | 93 (92.1) | reference | Ā | Ā |
ā16ā30 | 94 (10.9) | 769 (89.1) | 1.421 (0.67ā3.02) | Ā | Ā |
ā31ā45 | 60 (10.3) | 524(89.7%.) | 1.33 (0.62ā2.88) | Ā | Ā |
ā46ā60 | 17 (6.8) | 233 (93.2) | 0.85 (0.35ā2.03) | Ā | Ā |
āā>ā61 | 7 (9) | 71 (91) | 1.15 (0.39ā3.31) | Ā | Ā |
TB-treatment history | |||||
āPreviously Rx cases | 60 (27.4) | 159 (72.6) | 4.6(3.24ā6.49) | 4.7 (3.30ā6.75) | 0.001 |
āNew cases | 126 (7.6) | 1531 (92.4) | reference | Ā | Ā |
HIV status | |||||
āPositive | 17 (14.5) | 100 (85.5) | 1.64 (0.956ā2.81) | Ā | Ā |
āNegative | 11 (14.3) | 66 (85.7) | 1.61(0.832ā3.12) | Ā | Ā |
āUnknown | 158 (9.4) | 1524 (90.6) | reference | Ā | Ā |